PROTIA, a global leader in in-vitro diagnostic medical devices, will present its comprehensive veterinary diagnostic product line at the Western Veterinary Conference (WVC) in Las Vegas, demonstrating advanced technologies for animal health monitoring and disease prevention.
The company will showcase three primary diagnostic products: 'ANITIA Canine/Feline IgE', 'ANITIA Equine IgE', and 'AniCheck Bovine/Equine IgG'. These technologies offer rapid and accurate diagnostic capabilities for identifying allergens and measuring immune system health across multiple animal species.
The 'ANITIA Canine/Feline IgE' diagnostic kit enables veterinarians to quickly identify pet allergies, facilitating targeted treatment strategies. Similarly, the 'ANITIA Equine IgE' product uses a Parallel Line Array system to diagnose 120 potential allergens in horse serum, providing comprehensive insight into equine health.
A standout innovation is the 'AniCheck Bovine/Equine IgG' test, which measures colostrum immunoglobulin concentrations within 10 minutes. This technology can potentially improve newborn animal survival rates by ensuring high-quality immune substance transfer from mother to offspring.
With over 20,000 expected visitors and 600 participating companies, the WVC represents a critical platform for PROTIA to expand its global veterinary market presence. The conference provides an opportunity to introduce innovative diagnostic technologies and establish international collaborations.
PROTIA's CEO Lim Kook-Jin emphasized the company's commitment to developing advanced diagnostic technologies that support comprehensive health management for both companion and large animals, signaling continued investment in veterinary medical innovation.
